Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by GREGORY N FULLER and IAN E MCCUTCHEON.
GREGORY N FULLER
Connection Strength
1.158
IAN E MCCUTCHEON
  1. Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Oct; 181(4):397-407.
    View in: PubMed
    Score: 0.175
  2. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11.
    View in: PubMed
    Score: 0.124
  3. Metastatic melanoma to the pituitary gland. Can J Neurol Sci. 2007 Aug; 34(3):322-7.
    View in: PubMed
    Score: 0.075
  4. Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas. Ann Diagn Pathol. 2005 Feb; 9(1):6-10.
    View in: PubMed
    Score: 0.063
  5. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004 Nov; 28(11):1532-6.
    View in: PubMed
    Score: 0.062
  6. Textiloma (gossypiboma) mimicking recurrent intracranial tumor. Arch Pathol Lab Med. 2004 Jul; 128(7):749-58.
    View in: PubMed
    Score: 0.061
  7. Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun. 2024 May 02; 15(1):3728.
    View in: PubMed
    Score: 0.060
  8. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro Oncol. 2004 Jan; 6(1):9-14.
    View in: PubMed
    Score: 0.059
  9. Subependymomas of the fourth ventricle: To operate or not to operate? J Clin Neurosci. 2023 Dec; 118:147-152.
    View in: PubMed
    Score: 0.058
  10. Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad026.
    View in: PubMed
    Score: 0.056
  11. Melanoma metastatic to central neurocytoma: a novel case of tumor-to-tumor metastasis. J Neurooncol. 2003 Feb; 61(3):209-14.
    View in: PubMed
    Score: 0.055
  12. Long term outcomes following surgery for pineal region tumors. J Neurooncol. 2022 Feb; 156(3):491-498.
    View in: PubMed
    Score: 0.051
  13. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
    View in: PubMed
    Score: 0.045
  14. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.
    View in: PubMed
    Score: 0.041
  15. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395.
    View in: PubMed
    Score: 0.040
  16. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326.
    View in: PubMed
    Score: 0.038
  17. Sarcoma Brain Metastases: 28?Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967.
    View in: PubMed
    Score: 0.035
  18. Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas. Pituitary. 2012 Dec; 15(4):556-61.
    View in: PubMed
    Score: 0.027
  19. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol. 2006 Aug; 19(8):1034-41.
    View in: PubMed
    Score: 0.017
  20. The prognostic value of neurologic function in astrocytic spinal cord glioma. Neuro Oncol. 2003 07; 5(3):208-13.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.